Current Research in Translational Medicine

ISSN: 2452-3186
Frequency: 4 issues/year
Format: 210x280
First Published: 1952
Publication Language: English
Publisher: ELSEVIER
Copyright : © Elsevier Masson SAS

Current Research in Translational Medicine

Pr Ibrahim Yakoub-Agha, Haematology, Head of the Immune Cellular Therapy Unit, Lille University Hospital, Lille, France

Associate Editors

Dr Tamim Alsuliman, Dept.of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France: Hematology, oncology, hematopoietic cell transplantation and infectious diseases
Pr Halvard Bönig, Dept. of Tranlational Development of Cellular Therapeutics, Institute for Transfusion Medicine and Immune Hematology, Johann-Wolfgang-Goethe Medical University, Frankfurt, Germany: Traansfusion Medicine, immunohematology, hematopoietic stem cells, hematopoietic stem cell transplantation, cell and gene therapy manufacturing, ATMP regulation, ATMP manufacturing
Dr Eolia Brissot, Dept of Haematology and cellular therapy, Saint-Antoine hospital, APHP, Paris ; Sorbonne University, Paris, France: Hematology, acute leukemia, allogeneic and autologous stem cell transplantation, infections in immunocompromised patients
Pr Gandhi Damaj, Dept. of Haematology, Caen University Hospital, Caen, France: Hematology, specifically lymphoma and mastocytosis, and other myeloproliferative neoplasms
Dr Patrick Hayden, Dept. of Haematology, Saint James hospital, Dublin, Ireland: Haematology, myeloma, stem cell transplantation and acute leukaemia
Dr Dania Humaidan, Dept of Cognitive Modeling, Eberhard Karls University of Tuebingen and Max Planck International Research School for Intelligent Systems (IMPRS-IS), Tuebingen, Germany: Cognitive Modeling, Machine Learning, Computational Biology and Bioinformatic
Pr Myriam Labalette, Lab of Immunology and HLA, Lille University Hospital, Lille, France: Lymphoma, Mastocytosis, Autologous HSC transplantation
Pr Jérôme Larghero, Dept of Biotherapies, Saint Louis Hospital, Paris, France: Cell therapy, tissue engineering
Pr John A Snowden, Consultant Haematologist & Director of Blood and Marrow Transplantation, Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, UK: Haemato-oncology (clinical and diagnostics), haematopoietic cell transplantation/cellular therapy (for malignant and non-malignant diseases)

Current Research in Translational Medicine is a peer-reviewed journal, publishing worlwide clinical and basic research in the field of hematology, immunology, infectiology, hematopoietic cell transplantation, and cellular and gene therapy. The journal considers for publication English-language editorials, original articles, reviews, and short reports including case-reports. Contributions are intended to draw attention to experimental medicine and translational research. Current Research in Translational Medicine periodically publishes thematic issues and is indexed in all major international databases. 2018 Impact Factor: 2.353

Core areas covered in Current Research in Translational Medicine are:

  • Hematology
  • Immunology
  • Infectiology
  • Hematopoietic Cell Transplantation
  • Cellular and Gene Therapy

4 issues/year. E-only journal

2018 Journal Citation Reports (Clarivate Analytics, 2019)

Indexed in : PubMed/Medline, Current Contents/Life Sciences, Biosis Citation Index, Embase, Science Citation Index, ScienceDirect, Scopus, Pascal Francis

EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.